Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 9Venous Thromboembolism 4Prostatic Neoplasms 3Polycythemia Vera 3Neoplasms 3Breast Neoplasms 3Myeloproliferative Disorders 2Fallopian Tube Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Thrombocythemia, Essential 1Testicular Neoplasms 1Smoking Cessation 1Sarcoma 1Recurrence 1Primary Myelofibrosis 1Ovarian Neoplasms 1Ovarian Cancer Prevention 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Motor Activity 1Lung Neoplasms 1Liver Cirrhosis 1Leukemia, Hairy Cell 1Inflammation 1Hemorrhage 1Hematoma 1Fibrosis 1Endometrial Neoplasms 1

Interventions

Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Cancer Prevention × Aspirin × 1 year × Clear all
NCT03480776 2026-01-14

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

Canadian Cancer Trials Group

Phase 2 Active not recruiting
117 enrolled
Gynecologic

Ovarian Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡